524632
SHUKRAPHAR
Start SIP
Invest Now
Start SIP in SHUKRAPHAR
Shukra Pharmaceuticals live price: ₹31.89. It opened at ₹32 vs previous close ₹32; intraday high/low: ₹33/₹30. The 50 & 200 DMA stand at ₹39.73/₹35.73.
Shukra Pharmaceuticals Performance
- Today's Low
- ₹30
- Today's High
- ₹33
- 52 Week Low
- ₹12
- 52 Week High
- ₹65
- Open Price₹32
- Previous Close₹32
- Volume254,585
- 50 DMA₹39.73
- 100 DMA₹40.12
- 200 DMA₹35.73
Investment Returns
- Over 1 Month -22.47%
- Over 3 Month -44.04%
- Over 6 Month -7.43%
- Over 1 Year + 58.11%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 47.9
- PEG Ratio
- 0.2
- Market Cap Cr
- 1,396
- P/B Ratio
- 16.2
- Average True Range
- 2.67
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.9
- RSI
- 34.28
- MFI
- 28.9
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
Current Price
₹31.89
+
0.04
(0.13%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹36.41
- 50 Day
- ₹39.73
- 100 Day
- ₹40.12
- 200 Day
- ₹35.73
Resistance and Support
31.65
- R3 35.58
- R2 34.19
- R1 33.04
- S1 30.50
- S2 29.11
- S3 27.96
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-03-16 | Others | Inter-alia, to consider 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To Review the performance of the Chairman of the Company. 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2026-02-04 | Quarterly Results | (Revised) alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-11-13 | Quarterly Results | |
| 2025-10-03 | Others | Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-08-13 | Quarterly Results |
Shukra Pharmaceuticals F&O
About Shukra Pharmaceuticals
- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- Managing Director
- Mr. Dakshesh Rameshchandra Shah
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Popular Stocks
TCS Share PriceIRFC Share PriceIREDA Share PriceIRCTC Share PriceITC Share PriceWipro Share PriceSuzlon Share PriceTata Steel Share PriceYes Bank Share PriceHDFC Share PriceTata Power Share PriceInfosys Share PriceTata Motors Share PriceAdani Power Share PriceNHPC Share PriceRVNL Share PriceVedanta Share PricePaytm Share PriceLIC Share PriceBHEL Share Price
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹31 As on 05 April, 2026 | 18:50
The Market Cap of Shukra Pharmaceuticals is ₹1396.4 Cr As on 05 April, 2026 | 18:50
The P/E ratio of Shukra Pharmaceuticals is 47.9 As on 05 April, 2026 | 18:50
The PB ratio of Shukra Pharmaceuticals is 16.2 As on 05 April, 2026 | 18:50
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.